How Data and Informatics Intersect to Enable Precision Medicine to Reach its Full Potential
A Case Study of Europe and Beyond
Fighting for Their Lives – The Battle of the BPAN Warriors
BPAN Warriors: A Rare Disease Community’s Search for Connection, Collaboration and a Cure
Special Report: The Evolution of Biomarker Use in Clinical Trials for Cancer Treatments
Maximize healthcare performance by reducing unwarranted variations
Proteins: Life’s Simple Measures
Potential Impact of the VALID Act on IVD Manufacturers
Informatics Initiatives Exceed Value Expectations
The Future of Diagnostics in Precision Medicine
How Data and Informatics Intersect to Enable Precision Medicine to Reach its Full Potential
Editors Notes
Field Notes
A Case Study of Europe and Beyond
Fighting for Their Lives – The Battle of the BPAN Warriors
BPAN Warriors: A Rare Disease Community’s Search for Connection, Collaboration and a Cure
Cognoscienti
Special Report: The Evolution of Biomarker Use in Clinical Trials for Cancer Treatments
Maximize healthcare performance by reducing unwarranted variations
Proteins: Life’s Simple Measures
Potential Impact of the VALID Act on IVD Manufacturers
Informatics Initiatives Exceed Value Expectations
The Future of Diagnostics in Precision Medicine
Precision Tools
How Data and Informatics Intersect to Enable Precision Medicine to Reach its Full Potential
When we talk about value-based agreements, why don’t we talk about diagnostics?
How Might Gene Editing be Used to Cure Disease?
Quantification for precision medicine: A cure thing
Tweets
New post: Bristol Myers Squibb Receives European Commission Approval for Zeposia (ozanimod) for the Treatment of https://t.co/PjLpfjlnNI, - New post: Novartis Piqray® receives positive CHMP opinion to treat HR+/HER2- advanced breast cancer with a PIK3CA https://t.co/uvZsXDUAP2,
- New post: Phase III ADAURA trial showed treatment with Tagrisso after surgery with curative intent reduced the risk https://t.co/rd1StAFQNs,
